Walt Perlt

Ask VT AI
View News Summary
  • Eagles trade for Jets CB Michael Carter II to bolster their secondary for a title defense.
  • Novo Nordisk makes a bold $9B bid to acquire Metsera, a U.S. biotech firm, in a bid to outpace Pfizer's existing $4.9B deal and regain leadership in the competitive obesity drug market.
  • Altria's Q3 earnings beat estimates, but shares fell on a weak outlook and persistent category challenges.
20 hours
USA flag

United States Politics

Discover the latest news, candidates, 
and key topics of US politics

Ask VT AI
View News Summary
  • Eagles trade for Jets CB Michael Carter II to bolster their secondary for a title defense.
  • Novo Nordisk makes a bold $9B bid to acquire Metsera, a U.S. biotech firm, in a bid to outpace Pfizer's existing $4.9B deal and regain leadership in the competitive obesity drug market.
  • Altria's Q3 earnings beat estimates, but shares fell on a weak outlook and persistent category challenges.
20 hours
USA flag

United States Politics

Discover the latest news, candidates, 
and key topics of US politics

Most Reported By
News from Walt Perlt